ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Beligas
WAREHOUSE
International Warehouse 3
SUBSTANCE
Anti-Obesity Drug-9604
,
AOD 9604 is a modified variant of Growth Hormone, specifically a peptide composed of 191 amino acids. The peptide consists of the last 15 amino acids (176-191) of the Growth Hormone chain, referred to as GH Frag 176-191 or AOD 9604.
AOD 9604 is considered one of the most effective peptides for weight loss, offering additional advantages for fat reduction, enhanced metabolism, and more.
: Pituitary Gland
Stimulated GlandBenefits of AOD 9604Also known as Tyr-hGH Frag 176-191, AOD-9604 has been shown to possess excellent fat-burning abilities without triggering an increased appetite. It has no impact on blood sugar or tissue growth. AOD-9604 facilitates fat degradation and oxidation without engaging the hGH receptor, which means it operates through a distinct mechanism from hGH. Research involving rodents, pigs, dogs, and humans has demonstrated that AOD-9604 encourages fat release from predominantly obese fat cells while minimizing the formation of new fat and enhancing fat combustion. Remarkably, AOD-9604 is particularly effective at reducing abdominal fat.
The second most effective fat loss peptide is CJC-1295, which boosts overall GH levels in the body—counteracting the tendency to gain weight that often accompanies aging. If fat loss is your primary goal, it's advisable to steer clear of GHRP products (like GHRP-6, GHRP-2, or GHRH), as they can lead to increased hunger and elevated cortisol levels. In contrast, AOD-9604 does not trigger hunger or raise cortisol levels.
Research on AOD 9604Originally developed in the 1990s by Professor Frank Ng at Monash University in Australia, AOD-9604 was designed to be an anti-obesity drug that replicates the fat-burning effects of human growth hormone (HGH) without promoting muscle growth.
Recent findings have highlighted not only AOD 9604’s fat loss benefits but also its regenerative effects related to growth hormone. Current studies are exploring its potential applications in treating osteoarthritis, high cholesterol, and aiding bone and cartilage repair.
Results from an oral glucose tolerance test revealed that, unlike hGH, AOD 9604 does not negatively impact carbohydrate metabolism. No anti-AOD 9604 antibodies were found in any patients tested for them, and no serious adverse events related to AOD 9604 intake were reported in any studies.
ConclusionAOD 9604 demonstrated a strong safety and tolerability profile, comparable to a placebo. It did not elicit any of the negative effects associated with full-length hGH treatment. AOD 9604 has an outstanding safety record and has recently achieved Human GRAS status in the USA.